Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Victoria A Jennings"'
Autor:
Laura Evgin, Carolina S Ilkow, Marie-Claude Bourgeois-Daigneault, Christiano Tanese de Souza, Lawton Stubbert, Michael S Huh, Victoria A Jennings, Monique Marguerie, Sergio A Acuna, Brian A Keller, Charles Lefebvre, Theresa Falls, Fabrice Le Boeuf, Rebecca A Auer, John D Lambris, J Andrea McCart, David F Stojdl, John C Bell
Publikováno v:
Molecular Therapy: Oncolytics, Vol 3, Iss C (2016)
The systemic delivery of therapeutic viruses, such as oncolytic viruses or vaccines, is limited by the generation of neutralizing antibodies. While pseudotyping of rhabdoviruses with the lymphocytic choriomeningitis virus glycoprotein has previously
Externí odkaz:
https://doaj.org/article/03318fbb20d24026bc983751bf71f24d
Autor:
Matthew Holmes, Gina B. Scott, Samuel Heaton, Tyler Barr, Basem Askar, Louise M.E. Müller, Victoria A. Jennings, Christy Ralph, Cathy Burton, Alan Melcher, Peter Hillmen, Christopher Parrish, Fiona Errington-Mais
Publikováno v:
Molecular Therapy: Oncolytics, Vol 29, Iss , Pp 17-29 (2023)
Primary drug resistance and minimal residual disease are major challenges in the treatment of B cell neoplasms. Therefore, this study aimed to identify a novel treatment capable of eradicating malignant B cells and drug-resistant disease. Oncolytic v
Externí odkaz:
https://doaj.org/article/5203c050e9894f55a9405ad6fce9ab42
Autor:
Marie-Eve Wedge, Victoria A. Jennings, Mathieu J. F. Crupi, Joanna Poutou, Taylor Jamieson, Adrian Pelin, Giuseppe Pugliese, Christiano Tanese de Souza, Julia Petryk, Brian J. Laight, Meaghan Boileau, Zaid Taha, Nouf Alluqmani, Hayley E. McKay, Larissa Pikor, Sarwat Tahsin Khan, Taha Azad, Reza Rezaei, Bradley Austin, Xiaohong He, David Mansfield, Elaine Rose, Emily E. F. Brown, Natalie Crawford, Almohanad Alkayyal, Abera Surendran, Ragunath Singaravelu, Dominic G. Roy, Gemma Migneco, Benjamin McSweeney, Mary Lynn Cottee, Egon J. Jacobus, Brian A. Keller, Takafumi N. Yamaguchi, Paul C. Boutros, Michele Geoffrion, Katey J. Rayner, Avijit Chatterjee, Rebecca C. Auer, Jean-Simon Diallo, Derrick Gibbings, Benjamin R. tenOever, Alan Melcher, John C. Bell, Carolina S. Ilkow
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
RNA-based viruses can be engineered to express artificial microRNAs (amiRNAs). Here, the authors identify a candidate amiRNA that confers a replicative advantage to oncolytic viruses, enhancing their anticancer potency, and show that intercellular tr
Externí odkaz:
https://doaj.org/article/4c63ee51ae0d403a99532dab542cb349
Autor:
Fiona Collinson, Alan A. Melcher, Alan Anthoney, Darren J. Newton, Christy Ralph, Fiona Errington-Mais, Hardev Pandha, Richard G. Vile, Kevin J. Harrington, Chris J. Twelves, John Bell, Rebecca Auer, Giles J. Toogood, K.R. Prasad, Monika Lusky, Nicolas Stojkowitz, Kaidre Bendjama, Victoria A. Jennings, Barbara da Silva, Michelle Johnpulle, Jennifer Kingston, Emma Tidswell, Adam Peckham-Cooper, Rajiv V. Dave, Bethany Kuszlewicz, Samantha Turnbull, Karen J. Scott, Jonathan Carmichael, Emma J. West, Adel Samson
Supplementary Figure from Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31a91d9095b10d23365f7a59df1819f1
https://doi.org/10.1158/2326-6066.22544210.v1
https://doi.org/10.1158/2326-6066.22544210.v1
Autor:
Fiona Collinson, Alan A. Melcher, Alan Anthoney, Darren J. Newton, Christy Ralph, Fiona Errington-Mais, Hardev Pandha, Richard G. Vile, Kevin J. Harrington, Chris J. Twelves, John Bell, Rebecca Auer, Giles J. Toogood, K.R. Prasad, Monika Lusky, Nicolas Stojkowitz, Kaidre Bendjama, Victoria A. Jennings, Barbara da Silva, Michelle Johnpulle, Jennifer Kingston, Emma Tidswell, Adam Peckham-Cooper, Rajiv V. Dave, Bethany Kuszlewicz, Samantha Turnbull, Karen J. Scott, Jonathan Carmichael, Emma J. West, Adel Samson
Supplementary Data from Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e7c77efbfb3b8e77a0ae08974c11a08
https://doi.org/10.1158/2326-6066.22544216.v1
https://doi.org/10.1158/2326-6066.22544216.v1
Autor:
Fiona Collinson, Alan A. Melcher, Alan Anthoney, Darren J. Newton, Christy Ralph, Fiona Errington-Mais, Hardev Pandha, Richard G. Vile, Kevin J. Harrington, Chris J. Twelves, John Bell, Rebecca Auer, Giles J. Toogood, K.R. Prasad, Monika Lusky, Nicolas Stojkowitz, Kaidre Bendjama, Victoria A. Jennings, Barbara da Silva, Michelle Johnpulle, Jennifer Kingston, Emma Tidswell, Adam Peckham-Cooper, Rajiv V. Dave, Bethany Kuszlewicz, Samantha Turnbull, Karen J. Scott, Jonathan Carmichael, Emma J. West, Adel Samson
Improving the chances of curing patients with cancer who have had surgery to remove metastatic sites of disease is a priority area for cancer research. Pexa-Vec (Pexastimogene Devacirepvec; JX-594, TG6006) is a principally immunotherapeutic oncolytic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfd6fa47fd5f357dfeeffbe9b9017d6b
https://doi.org/10.1158/2326-6066.c.6550577
https://doi.org/10.1158/2326-6066.c.6550577
Autor:
Adel Samson, Emma J. West, Jonathan Carmichael, Karen J. Scott, Samantha Turnbull, Bethany Kuszlewicz, Rajiv V. Dave, Adam Peckham-Cooper, Emma Tidswell, Jennifer Kingston, Michelle Johnpulle, Barbara da Silva, Victoria A. Jennings, Kaidre Bendjama, Nicolas Stojkowitz, Monika Lusky, K.R. Prasad, Giles J. Toogood, Rebecca Auer, John Bell, Chris J. Twelves, Kevin J. Harrington, Richard G. Vile, Hardev Pandha, Fiona Errington-Mais, Christy Ralph, Darren J. Newton, Alan Anthoney, Alan A. Melcher, Fiona Collinson
Publikováno v:
Cancer Immunology Research. 10:745-756
Improving the chances of curing patients with cancer who have had surgery to remove metastatic sites of disease is a priority area for cancer research. Pexa-Vec (Pexastimogene Devacirepvec; JX-594, TG6006) is a principally immunotherapeutic oncolytic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950f3f33403d7506d7775a2e7565c5f9
https://doi.org/10.1158/2326-6066.cir-21-0171
https://doi.org/10.1158/2326-6066.cir-21-0171
Publikováno v:
Methods in Molecular Biology ISBN: 9781071629130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b58cf573d199c85f8ce15834fe3ba71d
https://doi.org/10.1007/978-1-0716-2914-7_10
https://doi.org/10.1007/978-1-0716-2914-7_10
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2614
Oncolytic viruses (OVs) rapidly and specifically replicate in and kill tumor cells. OV-targeted infection of malignant cells has the potential to create an "inflammatory storm" that stimulates both innate and adaptive anti-tumor immune responses. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::201b57e2fe7e5b968289ae75111416c4
https://pubmed.ncbi.nlm.nih.gov/36587124
https://pubmed.ncbi.nlm.nih.gov/36587124
Autor:
Timothy Kottke, Laura Evgin, Christopher B. Driscoll, Phonphimon Wongthida, Jill Thompson, Brady Zell, Adel Samson, Jason M. Tonne, Amanda L. Huff, Lewis R. Roberts, Elizabeth Ilett, Peter Selby, Alan Melcher, Kevin J. Harrington, Jacob van Vloten, Mitesh J. Borad, Hardev Pandha, Matthew Schuelke, Richard G. Vile, Mark A. McNiven, Victoria A. Jennings, Jose S. Pulido
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Nature Communications
Nature Communications
In our clinical trials of oncolytic vesicular stomatitis virus expressing interferon beta (VSV-IFNβ), several patients achieved initial responses followed by aggressive relapse. We show here that VSV-IFNβ-escape tumors predictably express a point-m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63459d370b5462aa7efd88a11b21a906
https://doaj.org/article/0057781c39ce43a79a6659f6e847a415
https://doaj.org/article/0057781c39ce43a79a6659f6e847a415